XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Unaudited Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023   40,609,915    
Beginning balance at Dec. 31, 2023 $ 26,532 $ 40 $ 271,594 $ (245,102)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares)   1,579    
Exercise of stock options 2   2  
Stock-based compensation 1,057   1,057  
Sale of common stock under Open Market Sale Agreement, net of issuance costs (in shares)   931,250    
Sale of common stock under Open Market Sale Agreement, net of issuance costs 2,282 $ 1 2,281  
Net loss (18,978)     (18,978)
Ending balance (in shares) at Mar. 31, 2024   41,542,744    
Ending balance at Mar. 31, 2024 10,895 $ 41 274,934 (264,080)
Beginning balance (in shares) at Dec. 31, 2023   40,609,915    
Beginning balance at Dec. 31, 2023 26,532 $ 40 271,594 (245,102)
Stockholders’ (Deficit) Equity        
Net loss (30,140)      
Ending balance (in shares) at Jun. 30, 2024   41,544,975    
Ending balance at Jun. 30, 2024 360 $ 41 275,561 (275,242)
Beginning balance (in shares) at Mar. 31, 2024   41,542,744    
Beginning balance at Mar. 31, 2024 10,895 $ 41 274,934 (264,080)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares)   2,231    
Exercise of stock options 2   2  
Stock-based compensation 625   625  
Net loss (11,162)     (11,162)
Ending balance (in shares) at Jun. 30, 2024   41,544,975    
Ending balance at Jun. 30, 2024 $ 360 $ 41 275,561 (275,242)
Beginning balance (in shares) at Dec. 31, 2024 41,750,109 41,750,109    
Beginning balance at Dec. 31, 2024 $ (27,909) $ 41 277,629 (305,579)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares)   37,987    
Exercise of stock options 5   5  
Stock-based compensation 508   508  
Net loss (9,266)     (9,266)
Ending balance (in shares) at Mar. 31, 2025   41,788,096    
Ending balance at Mar. 31, 2025 $ (36,662) $ 41 278,142 (314,845)
Beginning balance (in shares) at Dec. 31, 2024 41,750,109 41,750,109    
Beginning balance at Dec. 31, 2024 $ (27,909) $ 41 277,629 (305,579)
Stockholders’ (Deficit) Equity        
Exercise of stock options (in shares) 37,987      
Net loss $ (19,040)      
Ending balance (in shares) at Jun. 30, 2025 41,788,096 41,788,096    
Ending balance at Jun. 30, 2025 $ (46,005) $ 41 278,573 (324,619)
Beginning balance (in shares) at Mar. 31, 2025   41,788,096    
Beginning balance at Mar. 31, 2025 (36,662) $ 41 278,142 (314,845)
Stockholders’ (Deficit) Equity        
Stock-based compensation 431   431  
Net loss $ (9,774)     (9,774)
Ending balance (in shares) at Jun. 30, 2025 41,788,096 41,788,096    
Ending balance at Jun. 30, 2025 $ (46,005) $ 41 $ 278,573 $ (324,619)